These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 35172040)

  • 1. Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition.
    Mills L; Lintzeris N; O'Malley M; Arnold JC; McGregor IS
    Drug Alcohol Rev; 2022 Jul; 41(5):1095-1108. PubMed ID: 35172040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal.
    Lapham GT; Matson TE; Bobb JF; Luce C; Oliver MM; Hamilton LK; Bradley KA
    JAMA Netw Open; 2023 Aug; 6(8):e2328934. PubMed ID: 37642968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of cannabis use disorder among individuals using medical cannabis at admission to inpatient treatment for substance use disorders.
    N S Gendy M; Taisir R; Sousa S; Costello J; Rush B; Busse JW; Mackillop J
    Addict Behav; 2023 Jul; 142():107667. PubMed ID: 36893511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State Cannabis Legalization and Cannabis Use Disorder in the US Veterans Health Administration, 2005 to 2019.
    Hasin DS; Wall MM; Choi CJ; Alschuler DM; Malte C; Olfson M; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Fink DS; Livne O; Mannes Z; Sherman S; Saxon AJ
    JAMA Psychiatry; 2023 Apr; 80(4):380-388. PubMed ID: 36857036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004-2019.
    Mauro PM; Gutkind S; Askari MS; Hasin DS; Samples H; Mauro CM; Annunziato EM; Boustead AE; Martins SS
    Drug Alcohol Depend; 2024 Apr; 257():111113. PubMed ID: 38382162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use.
    Shmulewitz D; Budney AJ; Borodovsky JT; Bujno JM; Walsh CA; Struble CA; Livne O; Habib MI; Aharonovich E; Hasin DS
    J Psychiatr Res; 2023 Jul; 163():211-221. PubMed ID: 37224773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis use disorder in patients with chronic pain: overestimation and underestimation in a cross-sectional observational study in 3 German pain management centres.
    Bialas P; Böttge-Wolpers C; Fitzcharles MA; Gottschling S; Konietzke D; Juckenhöfel S; Madlinger A; Welsch P; Häuser W
    Pain; 2023 Jun; 164(6):1303-1311. PubMed ID: 36327134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical marijuana state.
    Padwa H; Huang D; Mooney L; Grella CE; Urada D; Bell DS; Bass B; Boustead AE
    Subst Abuse Treat Prev Policy; 2022 May; 17(1):36. PubMed ID: 35527269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use.
    Fink DS; Shmulewitz D; Mannes ZL; Stohl M; Livne O; Wall M; Hasin DS
    J Psychiatr Res; 2022 Nov; 155():387-394. PubMed ID: 36182768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of DSM-5 cannabis use disorders in a nationally representative sample of sexual minorities.
    Boyd CJ; Veliz PT; McCabe SE
    Subst Abus; 2020; 41(2):191-195. PubMed ID: 31638867
    [No Abstract]   [Full Text] [Related]  

  • 11. A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol.
    Bhardwaj AK; Mills L; Doyle M; Sahid A; Montebello M; Monds L; Arunogiri S; Haber P; Lorenzetti V; Lubman DI; Malouf P; Harrod ME; Dunlop A; Freeman T; Lintzeris N
    BMC Psychiatry; 2024 Mar; 24(1):175. PubMed ID: 38433233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002-2016.
    Santaella-Tenorio J; Levy NS; Segura LE; Mauro PM; Martins SS
    Drug Alcohol Depend; 2019 Dec; 205():107621. PubMed ID: 31698323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis use disorders among adults in the United States during a time of increasing use of cannabis.
    Compton WM; Han B; Jones CM; Blanco C
    Drug Alcohol Depend; 2019 Nov; 204():107468. PubMed ID: 31586809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nondisordered Cannabis Use Among US Adolescents.
    Sultan RS; Zhang AW; Olfson M; Kwizera MH; Levin FR
    JAMA Netw Open; 2023 May; 6(5):e2311294. PubMed ID: 37133862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Cannabis Use Disorder with Major Adverse Cardiac and Cerebrovascular Events in Older Non-Tobacco Users: A Population-Based Analysis.
    Mondal A; Dadana S; Parmar P; Mylavarapu M; Dong Q; Butt SR; Kali A; Bollu B; Desai R
    Med Sci (Basel); 2024 Feb; 12(1):. PubMed ID: 38390863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States.
    Wu LT; Zhu H; Mannelli P; Swartz MS
    Drug Alcohol Depend; 2017 Aug; 177():153-162. PubMed ID: 28599214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with the timing and onset of cannabis use and cannabis use disorder: results from the 2007 Australian National Survey of Mental Health and Well-Being.
    Butterworth P; Slade T; Degenhardt L
    Drug Alcohol Rev; 2014 Sep; 33(5):555-64. PubMed ID: 25186194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical Cannabis and Past-Year Cannabis Use Disorder Among Adult Recreational Users in the United States: Results From a Nationally Representative Sample.
    Rubin-Kahana DS; Hassan AN; Sanches M; Le Foll B
    Front Psychiatry; 2022; 13():836908. PubMed ID: 35432009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Pain, Cannabis Legalization and Cannabis Use Disorder in Veterans Health Administration Patients, 2005 to 2019.
    Hasin DS; Wall MM; Alschuler D; Mannes ZL; Malte C; Olfson M; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Fink DS; Livne O; McDowell Y; Sherman S; Saxon AJ
    medRxiv; 2023 Jul; ():. PubMed ID: 37503049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18).
    Lintzeris N; Mills L; Suraev A; Bravo M; Arkell T; Arnold JC; Benson MJ; McGregor IS
    Harm Reduct J; 2020 Jun; 17(1):37. PubMed ID: 32513180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.